20 件 ・ 関連度順
概要と使いどころ
Prepares and validates research-only clinical decision-support evaluation, evidence-profile, cohort, survival, biomarker/model, privacy, and governance artifacts. Supports aggregate or synthetic research documentation and traceability, excluding patient care and live clinical operation.
日本語の概要は準備中です。原文の説明を表示しています。
Prepare and validate research-only clinical decision-support evaluation, evidence-profile, cohort, survival, biomarker/model, privacy, and governance artifacts. Use for aggregate or synthetic research documentation and traceability—not patient care or live clinical operation.
日本語の概要は準備中です。原文の説明を表示しています。
Research uncertain questions with an explicit, user-approved web search or ChatGPT consultation, then present options and wait for implementation approval.
日本語の概要は準備中です。原文の説明を表示しています。
Use when managing the money for an internal R&D program or portfolio — building a multi-period program budget with the F&A (indirect) split, tracking burn rate and runway against value-inflection milestones, or routing R&D cost items to a capitalize-vs-expense determination. Every budget output surfaces its assumptions block; capitalize-vs-expense is decision-support only and routes to a named finance owner — it never books an entry or decides accounting treatment. Distinct from finance/financial-analysis (corporate DCF, close, valuation) and research/grants (funding discovery — this manages money already won).
日本語の概要は準備中です。原文の説明を表示しています。
Present options with trade-offs for informed decision-making — use when choosing between approaches
日本語の概要は準備中です。原文の説明を表示しています。
Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). Supports GRADE evidence grading, statistical analysis (hazard ratios, survival curves, waterfall plots), biomarker integration, and regulatory compliance. Outputs publication-ready LaTeX/PDF format optimized for drug development, clinical research, and evidence synthesis.
日本語の概要は準備中です。原文の説明を表示しています。
Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). ...
日本語の概要は準備中です。原文の説明を表示しています。
Designing interactive calculators (ROI calculators, pricing estimators, savings projections, mortgage calculators, custom assessments) that deliver real decision-support value while serving as lead magnets and qualified-traffic generators. Honest about vanity-calculator (no real value), lead-trap (hides the answer behind email), and transparent-decision-tool (gives the result and earns the email through tiered value) patterns. Triggers on calculator, ROI calculator, pricing estimator, savings calculator, custom calculator, interactive tool, decision tool, financial calculator. Also triggers when an audience needs a calculation-driven lead magnet, when a vanity calculator is producing leads but no qualified ones, or when a calculator is being scoped for the first time.
日本語の概要は準備中です。原文の説明を表示しています。
Evidence-based clinical decision support and diagnostic reasoning
日本語の概要は準備中です。原文の説明を表示しています。
Guidelines for clinical decision support (CDS) documents: biomarker-stratified cohort analyses and GRADE-graded treatment reports. Covers structure, executive summaries, evidence grading (1A–2C), stats (HR, CI, survival), and biomarker integration. Use for pharma research docs, clinical guidelines, regulatory submissions.
日本語の概要は準備中です。原文の説明を表示しています。
Provide data-driven decision support for construction. Analyze multiple factors and recommend optimal project decisions.
日本語の概要は準備中です。原文の説明を表示しています。
Research uncertain questions with an explicit, user-approved web search or ChatGPT consultation, then present options and wait for implementation approval.
日本語の概要は準備中です。原文の説明を表示しています。
Addresses healthcare AI privacy at the intersection of HIPAA and the EU AI Act for clinical decision support systems. Covers training data PHI handling, model transparency and explainability, patient rights in algorithmic decisions, FDA/OCR regulatory coordination, and bias monitoring. Keywords: healthcare AI, HIPAA, AI Act, clinical decision support, PHI training data, model transparency.
日本語の概要は準備中です。原文の説明を表示しています。
Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). Supports GRADE evidence grading, statistical analysis (hazard ratios, survival curves, waterfall plots), biomarker integration, and regulatory compliance. Outputs publication-ready LaTeX/PDF format optimized for drug development, clinical research, and evidence synthesis.
日本語の概要は準備中です。原文の説明を表示しています。
Turn a raw idea into ONE honest recommendation: interview one question at a time until the problem, requirements, goals, non-goals, and constraints are CONFIRMED, then deliver a single verdict — do, don't, cheaper alternatives, trade-offs, ordered checklist, success metrics. Required: the user wants exactly ONE recommendation — not options, not a debate — and their framing is open to challenge (advise may answer a different question than the one asked). Triggers on "what should I do about X", "advise me on X", "am I approaching this right", "is this the right move". Do NOT use to be interrogated with no recommendation (→ mk:grill) — advise also interviews one question at a time, but only to reach a verdict. Do NOT use when the framing is settled and only the options are open (→ mk:brainstorming). Do NOT use to decide whether something is worth building (→ mk:office-hours). Do NOT use when you want several perspectives to argue it out (→ mk:party).
日本語の概要は準備中です。原文の説明を表示しています。
Apply recognition-primed decision making to agents operating under time pressure, uncertainty, and ambiguous cues. Use for situation assessment, RPD-style action selection, and decision-support design in operational settings. NOT for batch optimization, static planning with full information, or tasks where exhaustive search is cheap and harmless.
日本語の概要は準備中です。原文の説明を表示しています。
Knowledge base from the NASA Cost Estimating Handbook (CEH) v4.0. Use for NASA's 12-step, three-part cost estimating process (Project Definition, Cost Methodology, Cost Estimate); the WBS, CADRe, and ONCE data backbone; estimating methodologies (analogy, parametric/CER, engineering build-up, EVM, Delphi); ground rules and assumptions, data normalization and inflation (BY/CY/RY); the point-estimate-to-S-curve cost-risk chain and Unallocated Future Expense (UFE) reserves; Joint Cost and Schedule Confidence Level (JCL) analysis via probabilistic cost-loaded schedules; decision-support analyses (sensitivity, trade studies, make/lease-vs-buy, affordability, CAIV); and economic analysis (discounting, NPV, OMB Circular A-94). The cost-estimating complement to NASA's SE and risk packs. Does NOT reproduce the handbook's tool-specific procedures, worked examples, or appendix-depth methods (it names the appendices), nor cover full DoD/GAO cost guides, schedule construction, or formal risk management beyond the cost interface.
日本語の概要は準備中です。原文の説明を表示しています。
Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). Supports GRADE evidence grading, statistical analysis (hazard ratios, survival curves, waterfall plots), biomarker integration, and regulatory compliance. Outputs publication-ready LaTeX/PDF format optimized for drug development, clinical research, and evidence synthesis.
日本語の概要は準備中です。原文の説明を表示しています。
Apply recognition-primed decision making to agents operating under time pressure, uncertainty, and ambiguous cues. Use for situation assessment, RPD-style action selection, and decision-support design in operational settings. NOT for batch optimization, static planning with full information, or tasks where exhaustive search is cheap and harmless.
日本語の概要は準備中です。原文の説明を表示しています。
Apply recognition-primed decision making to agents operating under time pressure, uncertainty, and ambiguous cues. Use for situation assessment, RPD-style action selection, and decision-support design in operational settings. NOT for batch optimization, static planning with full information, or tasks where exhaustive search is cheap and harmless.
日本語の概要は準備中です。原文の説明を表示しています。